Stock OSE OSE IMMUNOTHERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Consensus OSE Immunotherapeutics

Equities

OSE

FR0012127173

Market Closed - Euronext Paris
Other stock markets
 11:35:02 2024-05-02 am EDT 		5-day change 1st Jan Change
6.24 EUR +10.64% Intraday chart for OSE Immunotherapeutics +4.52% +45.79%
Apr. 17 OSE: licensing agreement with AbbVie enters into force CF
Apr. 17 OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie MT

Evolution of the average Target Price on OSE Immunotherapeutics

Price target over the last 5 years

History of analyst recommendation changes

8a711563f796bf0a789b26b6f6ea411._hLuMFsVo1vg8NNMs_dmCFUJLQXdK49HCMPIZj4LY-Q.iXDXXRBA_BzSw5FhwJ4_fB9dAGntZOgoZJLxCWpDKrHOI6BHE1zuMta_pA~e7553bf77367eb9dcaa702a5a3edb66c

Analyst Recommendations on OSE Immunotherapeutics

OSE IMMUNOTHERAPEUTICS : Degroof Petercam reiterates buy recommendation CF
OSE IMMUNO : Oddo BHF confirms its recommendation CF
OSE IMMUNO : Invest Securities confirms its recommendation CF
OSE IMMUNO : Invest Securities confirms its recommendation CF
Ose Immuno: share price falls, broker lowers target CF
OSE IMMUNO : Invest Securities lowers its target CF
TODAY'S ANALYST RECOMMENDATIONS : Barclays, Ford, Microsoft, Oracle, Lloyds... Our Logo
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.24 EUR
Average target price
7.15 EUR
Spread / Average Target
+14.58%
High Price Target
7.3 EUR
Spread / Highest target
+16.99%
Low Price Target
7 EUR
Spread / Lowest Target
+12.18%

Consensus detail

Consensus revision (last 18 months)

Ratings for OSE Immunotherapeutics

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. OSE Stock
  4. Consensus OSE Immunotherapeutics